Nigerian star player happy to be back to England premier league after spending more seasons at Spanish Club Villarreal.
Danjuma will be at Tottenham for six months as the agreement between both clubs, buy option also included. Medical tests are fully done and deal signed and now Danjuma is looking forward to work with Antonio Conte this season.
Transfer expert Fabrizio Romano confirms Gollini is undergoing his medical with the Partenopei now and soon it will be Sirigu’s turn in Florence.
According to reports in Italy, the ex Tottenham and Antanta keeper will move to the Stadio Maradona on loan with an option to buy for €8m, while it should be a dry loan deal until the end of the season for Sirigu.
Oscar will arrive at Salzburg in next hour for medical tests amid his move from Maccabi Tel Aviv, Salzburg will pay €7M to Israel club as part of agreement.
Content created and supplied by: Sportsupdates (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More